Terms: = Colorectal cancer AND ETV1, DKFZp781L0674, 2115, ENSG00000006468, ER81, MGC120533, MGC104699, MGC120534 AND Treatment
8 results:
1. etv1 Positively Correlated With Immune Infiltration and Poor Clinical Prognosis in colorectal cancer.
Shen X; Zhou C; Feng H; Li J; Xia T; Cheng X; Zhao R; Zou D
Front Immunol; 2022; 13():939806. PubMed ID: 35860243
[TBL] [Abstract] [Full Text] [Related]
2. Impact of relative dose intensity of oxaliplatin in adjuvant therapy among stage III colon cancer patients on early recurrence: a retrospective cohort study.
Żok J; Bieńkowski M; Radecka B; Korniluk J; Adamowicz K; Duchnowska R
BMC Cancer; 2021 May; 21(1):529. PubMed ID: 33971834
[TBL] [Abstract] [Full Text] [Related]
3. Glucose-Regulated Protein 94 Mediates the Proliferation and Metastasis through the Regulation of etv1 and MAPK Pathway in colorectal cancer.
Batzorig U; Wei PL; Wang W; Huang CY; Chang YJ
Int J Med Sci; 2021; 18(11):2251-2261. PubMed ID: 33967600
[TBL] [Abstract] [Full Text] [Related]
4. Molecularly annotation of mouse avatar models derived from patients with colorectal cancer liver metastasis.
Wang J; Xing B; Liu W; Li J; Wang X; Li J; Yang J; Ji C; Li Z; Dong B; Gao J; Shen L
Theranostics; 2019; 9(12):3485-3500. PubMed ID: 31281492
[No Abstract] [Full Text] [Related]
5. ETS (E26 transformation-specific) up-regulation of the transcriptional co-activator TAZ promotes cell migration and metastasis in prostate cancer.
Liu CY; Yu T; Huang Y; Cui L; Hong W
J Biol Chem; 2017 Jun; 292(22):9420-9430. PubMed ID: 28408625
[TBL] [Abstract] [Full Text] [Related]
6. CDX2 as a Prognostic Biomarker in Stage II and Stage III Colon cancer.
Dalerba P; Sahoo D; Paik S; Guo X; Yothers G; Song N; Wilcox-Fogel N; Forgó E; Rajendran PS; Miranda SP; Hisamori S; Hutchison J; Kalisky T; Qian D; Wolmark N; Fisher GA; van de Rijn M; Clarke MF
N Engl J Med; 2016 Jan; 374(3):211-22. PubMed ID: 26789870
[TBL] [Abstract] [Full Text] [Related]
7. Analyses of 7,635 Patients with colorectal cancer Using Independent Training and Validation Cohorts Show That rs9929218 in CDH1 Is a Prognostic Marker of Survival.
Smith CG; Fisher D; Harris R; Maughan TS; Phipps AI; Richman S; Seymour M; Tomlinson I; Rosmarin D; Kerr D; Chan AT; Peters U; Newcomb PA; Idziaszczyk S; West H; Meade A; Kaplan R; Cheadle JP
Clin Cancer Res; 2015 Aug; 21(15):3453-61. PubMed ID: 25873087
[TBL] [Abstract] [Full Text] [Related]
8. Capecitabine and mitomycin-C in the therapy of pretreated patients with metastatic colorectal cancer: single center retrospective study with 36 patients.
Vrdoljak E; Omrcen T; Boban M; Hrepic D
J BUON; 2008; 13(4):513-8. PubMed ID: 19145672
[TBL] [Abstract] [Full Text] [Related]
